Solventum Corporation (SOLV) is a publicly traded Healthcare sector company. As of July 5, 2026, SOLV trades at $78.27 with a market cap of $13.55B and a P/E ratio of 8.76. SOLV moved -0.10% today. Year to date, SOLV is -2.36%; over the trailing twelve months it is +0.03%. Its 52-week range spans $60.70 to $88.20. Analyst consensus is buy with an average price target of $83.00. Rallies surfaces SOLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SOLV, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $78.27 |
| Market Cap | $13.55B |
| P/E Ratio | 8.76 |
| EPS | $8.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $88.20 |
| 52-Week Low | $60.70 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $8.32B |
| Net Income | $1.56B |
| Gross Margin | 53.47% |
10 analysts cover SOLV: 0 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $83.00.